Dr Katims on the Utility of the MSK-ACCESS Assay in Node+ MIBC
Andrew Katims, MD, MPH, discusses the utility of a circulating tumor DNA assay (MSK-ACCESS) in patients with node-positive muscle-invasive bladder cancer.
Source: onclive.com
Stay updated with breaking news from Msk Access. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Andrew Katims, MD, MPH, discusses the utility of a circulating tumor DNA assay (MSK-ACCESS) in patients with node-positive muscle-invasive bladder cancer.